<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//supportsight.org/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://supportsight.org/2019/10/09/new-treatment-approved-for-wet-age-related-macular-degeneration/</loc>
		<lastmod>2019-10-09T16:40:17+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2019/10/beovu-by-novartis.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>http://www.supportsight.org/wp-content/uploads/2019/10/beovu-by-novartis.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2020/02/19/local-based-foundation-sets-its-sights-on-saving-sight-for-millions/</loc>
		<lastmod>2020-02-26T17:55:45+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2020/02/eyeball.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2020/02/eyeball.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2021/03/25/new-website-for-people-impacted-by-age-related-macular-degeneration-launched-by-patient-advocacy-groups/</loc>
		<lastmod>2021-03-25T18:51:42+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2021/03/amd.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2021/05/17/the-step-program-supporting-solutions-from-patient-advocacy-organizations/</loc>
		<lastmod>2021-05-17T11:48:14+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2021/05/supportsight-foundation-and-novartis-step-national-award-winner.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2021/09/17/next-stop-amd-central/</loc>
		<lastmod>2021-09-17T17:50:12+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2021/09/241631426_578082093633963_5933565477130235982_n.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2021/09/17/exciting-new-progress-to-find-a-cure-for-macular-degeneration/</loc>
		<lastmod>2021-09-17T17:53:27+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2021/09/242158227_582804169828422_8077783505234953032_n.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2021/10/26/invitation-for-patients-and-caregivers-to-participate-in-a-survey-about-dry-age-related-macular-degeneration-geographic-atrophy/</loc>
		<lastmod>2021-10-26T16:14:30+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2021/10/mosaic-logo.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2021/10/mosaic-global-study-partners.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2022/06/01/apellis-announces-submission-of-new-drug-application-to-the-fda-for-pegcetacoplan-for-geographic-atrophy/</loc>
		<lastmod>2022-06-29T11:31:22+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2022/06/apellis-pharmaceuticals-600.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2023/11/03/alkeus-pharmaceuticals-presents-positive-gildeuretinol-trial-results-at-american-academy-of-ophthalmology-demonstrating-significant-slowing-of-retinal-atrophic-lesions-in-stargardt-disease/</loc>
		<lastmod>2024-02-13T14:13:56+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2023/11/alkeus-pharmaceuticals.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2023/09/05/eylea-hd-injection-approved-by-fda-for-treatment-of-wet-age-related-macular-degeneration-wamd-diabetic-macular-edema-dme-and-diabetic-retinopathy-dr/</loc>
		<lastmod>2024-02-13T14:14:59+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2023/09/EYLEA-HD-Injection.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2023/08/11/two-year-pulsar-trial-results-for-aflibercept-8mg-demonstrate-durable-vision-gains-at-extended-dosing-intervals-in-wet-age-related-macular-degeneration/</loc>
		<lastmod>2024-02-13T14:15:51+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2023/08/EYLEA-HD-Injection2.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2023/07/31/syfovre-pegcetacoplan-injection-continued-to-demonstrate-increasing-treatment-effects-over-30-months-in-patients-with-geographic-atrophy-ga/</loc>
		<lastmod>2024-02-13T14:17:22+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2023/07/SYFOVRE.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2023/03/07/new-treatment-for-amd-accepted-for-fda-priority-review/</loc>
		<lastmod>2024-02-13T14:18:37+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2023/03/eyelea.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2022/10/20/healthcare-on-the-horizon-podcast-featuring-tssf/</loc>
		<lastmod>2024-02-13T14:19:28+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2022/10/healthcare-on-the-horizon-podcast.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2023/02/10/roches-vabysmo-shows-an-edge-over-regenerons-eylea-in-retina-drying/</loc>
		<lastmod>2024-08-22T15:52:05+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2024/08/roche-vabysmo.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2024/12/17/eylea-hd-aflibercept-injection-8-mg-phase-3-trial-meets-primary-endpoint-showing-improved-vision-with-extended-dosing-intervals-in-patients-with-macular-edema-following-retinal-vein-occlusion/</loc>
		<lastmod>2024-12-29T16:56:38+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2023/09/EYLEA-HD-Injection.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2025/05/20/healthy-eating-for-macular-degeneration/</loc>
		<lastmod>2025-06-05T14:49:33+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2025/05/healthy-eating-with-macular-degeneration.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2025/05/20/5-ways-to-support-someone-with-macular-degeneration-a-guide-for-caregivers/</loc>
		<lastmod>2025-06-05T14:50:49+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2025/05/5-Ways-to-Support-Someone-with-Macular-Degeneration-A-Guide-for-Caregivers.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2025/05/20/understanding-stargardt-disease-causes-symptoms-and-hope-for-the-future/</loc>
		<lastmod>2025-06-05T14:52:35+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2025/05/Understanding-Stargardt-Disease-Causes-Symptoms-and-Hope-for-the-Future.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://supportsight.org/2025/05/20/how-to-use-the-amsler-grid-to-monitor-macular-degeneration/</loc>
		<lastmod>2026-05-15T15:30:56+00:00</lastmod>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2025/05/How-to-Use-the-Amsler-Grid-to-Monitor-Macular-Degeneration.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://supportsight.org/wp-content/uploads/2025/06/amsler-grid-notepad.png</image:loc>
		</image:image>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->